Standard BioTools Stock Forecast
NASDAQ: LABIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 9:31 AM ET
LAB analyst consensus
Consensus (1 analysts)
none
Avg. price target
$1.35+103.80%
- Strong buy 0
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 1 Wall Street analyst covering Standard BioTools (2026-10-08), 0 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $1.35, with a high estimate of $1.35 and a low estimate of $1.35. The average target implies upside of 103.8% from the current price of $0.6624.
The spread between the highest and lowest targets is 0.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LAB.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 1 | 100% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $1.35 | +103.80% |
| Average target | $1.35 | +103.80% |
| High target | $1.35 | +103.80% |